Trade Resources Industry Views The US FDA Has Granted Final Approval for Mylan Pharmaceuticals' ANDA

The US FDA Has Granted Final Approval for Mylan Pharmaceuticals' ANDA

Apr 4, 2013

Tags: FDA, Acyclovir Ointment, Medicine

The US FDA has granted final approval for Mylan Pharmaceuticals' abbreviated new drug application (ANDA) for Acyclovir Ointment USP, 5%.

Acyclovir Ointment is the generic equivalent to Zovirax Ointment from Valeant International.

Mylan has begun immediate product shipment.

Zovirax Ointment is indicated for the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients.

Based on IMS Health data, US sales of Acyclovir Ointment USP, 5% were approximately $230m for the 12 months ending 31 December 2012.

Source: http://drugdelivery.pharmaceutical-business-review.com/news/fda-approves-mylans-anda-for-acyclovir-ointment-040413

Contribute Copyright Policy

FDA Approves Mylan's ANDA for Acyclovir Ointment

Topics: Health & Medicine

Hot Searches

Dental Chair Sterilization Bag Medical Gauze Sterilization Pouch Sterile Bag Heat Seal Pouches China Stethoscope Self Sealing Pouch Self Seal Pouches Sterile Pouch Sterilize Pouch Fda Standard Fda Approved Ce Iso Fda Certificate Fda Mask Fda Approval Fda Blood Collection China Fda Surgical Mask China Fda Approved Bag Fda Registered Dental Unit Fda Blood Pressure Fda Fda Registration Drug Test Fda Dental Chair Fda

The US FDA Has Granted Final Approval for Mylan Pharmaceuticals' ANDA

Related News

Hot Searches

Related Products